Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis

<div>Chest high-resolution computed tomography: November 2017 compared to last follow-up, September 2020. Reticular abnormalities, honeycombing aspects, and traction bronchiectasis compatible with usual interstitial pneumonia. Despite an initial progression, interstitial lung disease showed a substantial stability at the last follow-up.</div>

Case Reports in Medicine

fig2

Figure 2

Figure 2: Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 